Validation of Mayo clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry

By Singh M.   Rihal C.S.   Selzer F.   Kip K.E.   Detre K.   Holmes D.R.  

Journal of the American College of Cardiology, Vol. 42, Iss. 10, 2003-11 ,pp. : 1722-1728

Elsevier

Access to resources Recommend Favorite

The impact of cardiovascular comorbidities on the outcome of surgery for non-small-cell lung cancer

By Takenaka Tomoyoshi   Katsura Masakazu   Shikada Yasunori   Tsukamoto Syuichi   Takeo Sadanori  

Interactive CardioVascular and Thoracic Surgery, Vol. 16, Iss. 3, 2013-03 ,pp. : 270-274

Oxford University Press

Access to resources Recommend Favorite

Assessment of American Heart Association's Ideal Cardiovascular Health Metrics Among Employees of a Large Healthcare Organization: The Baptist Health South Florida Employee Study

By  

Clinical Cardiology, Vol. 38, Iss. 7, 2015-07 ,pp. : 422-429

John Wiley & Sons Inc

Access to resources Recommend Favorite

The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review

By Ferrari Roberto   Boersma Eric  

Expert Review of Cardiovascular Therapy, Vol. 11, Iss. 6, 2013-06 ,pp. : 705-717

Informa Healthcare

Access to resources Recommend Favorite

Reducing the Blood Pressure–Related Burden of Cardiovascular Disease: Impact of Achievable Improvements in Blood Pressure Prevention and Control

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 10, 2015-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite